Search Results

Your search matched 3 results


ICER Report on Pharmaceutical Insurance Coverage Puts Spotlight on Payers/PBMs | Blog

The Institute for Clinical and Economic Review (ICER) recently published its first Assessment of Barriers to Fair Access report examining coverage policies of 15 major commercial insurers


Prescription Drugs Covered under Medicare Part B Scrutinized as Part of ICER’s Annual Unsupported Price Increase (UPI) Report | Blog

As anticipated, the drug pricing watchdog group, the Institute for Clinical and Economic Review (ICER), published its fourth annual Unsupported Price Increase (UPI) Report on prescription drugs in the United States.


Drug Pricing Reform Legislation Resurrected by Democrats | Blog

Drug pricing legislation continues to forge ahead with a significant healthcare proposal back in play.